Management Team
Max Sims
Chief Executive Officer and Co-Founder
Max Sims
Chief Executive Officer and Co-Founder
Max Sims is the Chief Executive Officer and Co-Founder of MindTrace.
Sims co-founded MindTrace during graduate school to translate cutting-edge research into scalable patient impact. He received one of the country’s first STEM-designated MBAs from the University of Rochester’s Simon School of Business and holds a B.S. in Neuroscience and a B.A. in Business from the University of Rochester.
Sims serves as Principal Investigator for MindTrace’s National Institutes of Health and National Science Foundation SBIR awards, driving innovations in neuroscience and technology for brain surgery patients. He has guided MindTrace through highly selective accelerator programs, including Creative Destruction Lab and AlphaLab Health.
Recognized for his contributions, Sims was named to the 2022 Pittsburgh Business Times’ “30 Under 30” list, and MindTrace has been included in CB Insights’ Digital Health 150 List and named a “2023 Startup to Watch” by Pittsburgh Inno and Pittsburgh Technical.ly.
Max Sims is the Chief Executive Officer and Co-Founder of MindTrace.
Sims co-founded MindTrace during graduate school to translate cutting-edge research into scalable patient impact. He received one of the country’s first STEM-designated MBAs from the University of Rochester’s Simon School of Business and holds a B.S. in Neuroscience and a B.A. in Business from the University of Rochester.
Sims serves as Principal Investigator for MindTrace’s National Institutes of Health and National Science Foundation SBIR awards, driving innovations in neuroscience and technology for brain surgery patients. He has guided MindTrace through highly selective accelerator programs, including Creative Destruction Lab and AlphaLab Health.
Recognized for his contributions, Sims was named to the 2022 Pittsburgh Business Times’ “30 Under 30” list, and MindTrace has been included in CB Insights’ Digital Health 150 List and named a “2023 Startup to Watch” by Pittsburgh Inno and Pittsburgh Technical.ly.
Max Sims
Chief Executive Officer and Co-Founder
Max Sims is the Chief Executive Officer and Co-Founder of MindTrace.
Sims co-founded MindTrace during graduate school to translate cutting-edge research into scalable patient impact. He received one of the country’s first STEM-designated MBAs from the University of Rochester’s Simon School of Business and holds a B.S. in Neuroscience and a B.A. in Business from the University of Rochester.
Sims serves as Principal Investigator for MindTrace’s National Institutes of Health and National Science Foundation SBIR awards, driving innovations in neuroscience and technology for brain surgery patients. He has guided MindTrace through highly selective accelerator programs, including Creative Destruction Lab and AlphaLab Health.
Recognized for his contributions, Sims was named to the 2022 Pittsburgh Business Times’ “30 Under 30” list, and MindTrace has been included in CB Insights’ Digital Health 150 List and named a “2023 Startup to Watch” by Pittsburgh Inno and Pittsburgh Technical.ly.
Brad Mahon
Chief Science Officer and Co-Founder
Brad Mahon
Chief Science Officer and Co-Founder
Dr. Brad Mahon is Chief Scientific Officer and Co-Founder of MindTrace.
He holds a PhD from Harvard University and is a Professor in the Department of Psychology and the Neuroscience Institute at Carnegie Mellon University. Dr. Mahon is a cognitive neuroscientist with expertise in neuropsychological assessment and the optimization of personalized brain mapping protocols.
His research focuses on understanding disruption and recovery of neural systems in patients with brain tumors, epilepsy, stroke, and traumatic brain injury. Dr. Mahon is Co-Editor-in-Chief of Cognitive Neuropsychology, and the founding Scientific Director the Program for Translational Brain Mapping at the University of Rochester. His work has received more than $9 million in cumulative funding from the National Institutes of Health and the National Science Foundation.
Dr. Brad Mahon is Chief Scientific Officer and Co-Founder of MindTrace.
He holds a PhD from Harvard University and is a Professor in the Department of Psychology and the Neuroscience Institute at Carnegie Mellon University. Dr. Mahon is a cognitive neuroscientist with expertise in neuropsychological assessment and the optimization of personalized brain mapping protocols.
His research focuses on understanding disruption and recovery of neural systems in patients with brain tumors, epilepsy, stroke, and traumatic brain injury. Dr. Mahon is Co-Editor-in-Chief of Cognitive Neuropsychology, and the founding Scientific Director the Program for Translational Brain Mapping at the University of Rochester. His work has received more than $9 million in cumulative funding from the National Institutes of Health and the National Science Foundation.
Brad Mahon
Chief Science Officer and Co-Founder
Dr. Brad Mahon is Chief Scientific Officer and Co-Founder of MindTrace.
He holds a PhD from Harvard University and is a Professor in the Department of Psychology and the Neuroscience Institute at Carnegie Mellon University. Dr. Mahon is a cognitive neuroscientist with expertise in neuropsychological assessment and the optimization of personalized brain mapping protocols.
His research focuses on understanding disruption and recovery of neural systems in patients with brain tumors, epilepsy, stroke, and traumatic brain injury. Dr. Mahon is Co-Editor-in-Chief of Cognitive Neuropsychology, and the founding Scientific Director the Program for Translational Brain Mapping at the University of Rochester. His work has received more than $9 million in cumulative funding from the National Institutes of Health and the National Science Foundation.
Hugo Angulo
Chief Technical Officer and Co-Founder
Hugo Angulo
Chief Technical Officer and Co-Founder
Hugo Angulo is Chief Technical Officer and Co-Founder of MindTrace.
He holds a Master’s degree in Biotechnology Innovation and Computation from Carnegie Mellon University and brings extensive experience in medical imaging software, cloud-based systems, and high-performance computing.
His background includes building non-relational databases and scalable cloud storage architectures, serving as an ethical hacker and cybersecurity consultant for hospitals, and coordinating computational infrastructure for large neuroscience research laboratories.
Hugo Angulo is Chief Technical Officer and Co-Founder of MindTrace.
He holds a Master’s degree in Biotechnology Innovation and Computation from Carnegie Mellon University and brings extensive experience in medical imaging software, cloud-based systems, and high-performance computing.
His background includes building non-relational databases and scalable cloud storage architectures, serving as an ethical hacker and cybersecurity consultant for hospitals, and coordinating computational infrastructure for large neuroscience research laboratories.
Hugo Angulo
Chief Technical Officer and Co-Founder
Hugo Angulo is Chief Technical Officer and Co-Founder of MindTrace.
He holds a Master’s degree in Biotechnology Innovation and Computation from Carnegie Mellon University and brings extensive experience in medical imaging software, cloud-based systems, and high-performance computing.
His background includes building non-relational databases and scalable cloud storage architectures, serving as an ethical hacker and cybersecurity consultant for hospitals, and coordinating computational infrastructure for large neuroscience research laboratories.
Frank Fischer
Chairman of the Board
Key Staff
Jaimie Cole
Quality Management System Specialist
Jaimie Cole
Quality Management System Specialist
Jaimie Cole is the Quality Management System Specialist at MindTrace. In this role, he oversees all quality and regulatory processes. Jaimie holds a degree in Computer Engineering from Rochester Institute of Technology where he has also been an adjunct instructor. He is also a member of RIT’s Biomedical Engineering Industry Advisory Board. Prior to MindTrace, Jaimie led the technology team at iCardiac Technologies, a cardiac safety core lab. iCardiac was eventually acquired by ERT which is now called Clario. Jaimie is also an avid musician specializing in acoustic, electric, and bass guitar.
Jaimie Cole is the Quality Management System Specialist at MindTrace. In this role, he oversees all quality and regulatory processes. Jaimie holds a degree in Computer Engineering from Rochester Institute of Technology where he has also been an adjunct instructor. He is also a member of RIT’s Biomedical Engineering Industry Advisory Board. Prior to MindTrace, Jaimie led the technology team at iCardiac Technologies, a cardiac safety core lab. iCardiac was eventually acquired by ERT which is now called Clario. Jaimie is also an avid musician specializing in acoustic, electric, and bass guitar.
Jaimie Cole
Quality Management System Specialist
Jaimie Cole is the Quality Management System Specialist at MindTrace. In this role, he oversees all quality and regulatory processes. Jaimie holds a degree in Computer Engineering from Rochester Institute of Technology where he has also been an adjunct instructor. He is also a member of RIT’s Biomedical Engineering Industry Advisory Board. Prior to MindTrace, Jaimie led the technology team at iCardiac Technologies, a cardiac safety core lab. iCardiac was eventually acquired by ERT which is now called Clario. Jaimie is also an avid musician specializing in acoustic, electric, and bass guitar.
Veronica Benzing
Senior Technical Writer
Veronica Benzing
Senior Technical Writer
Veronica has over 25 years of Technical Writing experience, with 23 years of experience working in the FDA regulatory space. Veronica's passion is to help startups and small companies create and improve their processes as well as formatting documents. She believes that a company’s image is portrayed through documentation so that documentation must look good. Veronica has worked at/with 5 startups where she created their quality systems and their documentation from scratch. Her experience is mostly with companies that have software and software as a medical device as products.
In her free time, you will find Veronica trail running in the woods, spending time with her husband, Joel, and her daughter, Julia, reading, experimenting with creating new dishes and desserts, or traveling.
Veronica has over 25 years of Technical Writing experience, with 23 years of experience working in the FDA regulatory space. Veronica's passion is to help startups and small companies create and improve their processes as well as formatting documents. She believes that a company’s image is portrayed through documentation so that documentation must look good. Veronica has worked at/with 5 startups where she created their quality systems and their documentation from scratch. Her experience is mostly with companies that have software and software as a medical device as products.
In her free time, you will find Veronica trail running in the woods, spending time with her husband, Joel, and her daughter, Julia, reading, experimenting with creating new dishes and desserts, or traveling.
Veronica Benzing
Senior Technical Writer
Veronica has over 25 years of Technical Writing experience, with 23 years of experience working in the FDA regulatory space. Veronica's passion is to help startups and small companies create and improve their processes as well as formatting documents. She believes that a company’s image is portrayed through documentation so that documentation must look good. Veronica has worked at/with 5 startups where she created their quality systems and their documentation from scratch. Her experience is mostly with companies that have software and software as a medical device as products.
In her free time, you will find Veronica trail running in the woods, spending time with her husband, Joel, and her daughter, Julia, reading, experimenting with creating new dishes and desserts, or traveling.
Gabby Tumolo
Clinical Workflow Analyst
Gabby Tumolo
Clinical Workflow Analyst
Gabby Tumolo is a Clinical Workflow Analyst at MindTrace. As an undergraduate college student studying psychology-neuroscience, she has a strong drive for understanding how neurological deficits and diseases impact cognition.
Starting with MindTrace as an intern in the summer of 2025, she has since broadened her education and deepened her love for supporting new technologies to help neurosurgery patients preserve neruocognitive functioning.
Gabby Tumolo is a Clinical Workflow Analyst at MindTrace. As an undergraduate college student studying psychology-neuroscience, she has a strong drive for understanding how neurological deficits and diseases impact cognition.
Starting with MindTrace as an intern in the summer of 2025, she has since broadened her education and deepened her love for supporting new technologies to help neurosurgery patients preserve neruocognitive functioning.
Gabby Tumolo
Clinical Workflow Analyst
Gabby Tumolo is a Clinical Workflow Analyst at MindTrace. As an undergraduate college student studying psychology-neuroscience, she has a strong drive for understanding how neurological deficits and diseases impact cognition.
Starting with MindTrace as an intern in the summer of 2025, she has since broadened her education and deepened her love for supporting new technologies to help neurosurgery patients preserve neruocognitive functioning.
Advisors
Andrew Thompson
Business Advisor
Andrew Thompson
Business Advisor
Andrew Thompson is a Silicon Valley based Chief Executive, entrepreneur and investor with a 30-year track record of successful technology-based innovation. As a Founder and Chief-Executive he has raised over $750M in private, public and corporate capital for first-in-category companies and personally negotiated three successful M&A transactions with Fortune 50 enterprises.
From 2003 to 2020 he was Co-Founder, Chief Executive and Board Member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company’s digital medicine solutions dramatically improved clinical outcomes delivered by oral drugs and have the potential to enable a more sustainable model for innovation in pharmaceuticals that leverages the power of silicon, software and mobile devices.
He holds masters’ degrees in Engineering (Cambridge), Education (Stanford) and Business (Stanford GSB) and is a named inventor on over 50 issued patents.
Andrew Thompson is a Silicon Valley based Chief Executive, entrepreneur and investor with a 30-year track record of successful technology-based innovation. As a Founder and Chief-Executive he has raised over $750M in private, public and corporate capital for first-in-category companies and personally negotiated three successful M&A transactions with Fortune 50 enterprises.
From 2003 to 2020 he was Co-Founder, Chief Executive and Board Member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company’s digital medicine solutions dramatically improved clinical outcomes delivered by oral drugs and have the potential to enable a more sustainable model for innovation in pharmaceuticals that leverages the power of silicon, software and mobile devices.
He holds masters’ degrees in Engineering (Cambridge), Education (Stanford) and Business (Stanford GSB) and is a named inventor on over 50 issued patents.
Andrew Thompson
Business Advisor
Andrew Thompson is a Silicon Valley based Chief Executive, entrepreneur and investor with a 30-year track record of successful technology-based innovation. As a Founder and Chief-Executive he has raised over $750M in private, public and corporate capital for first-in-category companies and personally negotiated three successful M&A transactions with Fortune 50 enterprises.
From 2003 to 2020 he was Co-Founder, Chief Executive and Board Member of Proteus Digital Health, leading the company to unicorn status and a valuation of over $1.5B. The company’s digital medicine solutions dramatically improved clinical outcomes delivered by oral drugs and have the potential to enable a more sustainable model for innovation in pharmaceuticals that leverages the power of silicon, software and mobile devices.
He holds masters’ degrees in Engineering (Cambridge), Education (Stanford) and Business (Stanford GSB) and is a named inventor on over 50 issued patents.
George Savage
Business Advisor
George Savage
Business Advisor
George Savage is a Silicon Valley-based entrepreneur and inventor with a successful track-record offirst-in-category medical product innovation. As a founder, board member and C-level executive he has successfully taken multiple revolutionary ideas through the full lifecycle from conception to funding, development, regulatory approval, commercialization and exit.
Dr. Savage pioneered catheter-basedminimally-invasive surgery inside the heart, proceeding from concept to FDA premarket approval inonly three years. In 2014, he was named one of the 100 most inspiring people in the pharmaceutical industry by PharmaVoice.
From 2003 to 2020 Dr. Savage was Co-Founder and Chief Medical Officer of Proteus Digital Health,where he demonstrated the power of integrated digital feedback to improve outcomes for patientsprescribed oral pharmacotherapy. He won a landmark FDA approval for the first drug-devicecombination where the innovation was integrated silicon and software rather than novel chemistry orbiology.
George Savage holds a BS in Biomedical Engineering (Boston University), an MD (Tufts University) andan MBA (Stanford University).
George Savage is a Silicon Valley-based entrepreneur and inventor with a successful track-record offirst-in-category medical product innovation. As a founder, board member and C-level executive he has successfully taken multiple revolutionary ideas through the full lifecycle from conception to funding, development, regulatory approval, commercialization and exit.
Dr. Savage pioneered catheter-basedminimally-invasive surgery inside the heart, proceeding from concept to FDA premarket approval inonly three years. In 2014, he was named one of the 100 most inspiring people in the pharmaceutical industry by PharmaVoice.
From 2003 to 2020 Dr. Savage was Co-Founder and Chief Medical Officer of Proteus Digital Health,where he demonstrated the power of integrated digital feedback to improve outcomes for patientsprescribed oral pharmacotherapy. He won a landmark FDA approval for the first drug-devicecombination where the innovation was integrated silicon and software rather than novel chemistry orbiology.
George Savage holds a BS in Biomedical Engineering (Boston University), an MD (Tufts University) andan MBA (Stanford University).
George Savage
Business Advisor
George Savage is a Silicon Valley-based entrepreneur and inventor with a successful track-record offirst-in-category medical product innovation. As a founder, board member and C-level executive he has successfully taken multiple revolutionary ideas through the full lifecycle from conception to funding, development, regulatory approval, commercialization and exit.
Dr. Savage pioneered catheter-basedminimally-invasive surgery inside the heart, proceeding from concept to FDA premarket approval inonly three years. In 2014, he was named one of the 100 most inspiring people in the pharmaceutical industry by PharmaVoice.
From 2003 to 2020 Dr. Savage was Co-Founder and Chief Medical Officer of Proteus Digital Health,where he demonstrated the power of integrated digital feedback to improve outcomes for patientsprescribed oral pharmacotherapy. He won a landmark FDA approval for the first drug-devicecombination where the innovation was integrated silicon and software rather than novel chemistry orbiology.
George Savage holds a BS in Biomedical Engineering (Boston University), an MD (Tufts University) andan MBA (Stanford University).
Jeanne Iasella
Business Advisor
Jeanne Iasella
Business Advisor
Jeanne Colwell Iasella is a healthcare technology executive with deep domain expertise in healthcare informatics and extensive experience in corporate development and mergers and acquisitions. As a C-level executive and division leader, she has built and managed large-scale solution portfolios deployed to healthcare systems globally.
Currently, she is Managing Director of Life Sciences at Innovation Works, one of the most active seed-stage investment organizations in the country. Previously, she served as Chief Solutions Officer at TeleTracking Technologies, where she managed a portfolio of more than 20 healthcare solutions deployed worldwide. Before that, she led large corporate development and business line divisions at Bayer Health and Medrad, bringing together her combined strengths in healthcare informatics, strategic acquisitions and operational leadership.
Jeanne Colwell Iasella is a healthcare technology executive with deep domain expertise in healthcare informatics and extensive experience in corporate development and mergers and acquisitions. As a C-level executive and division leader, she has built and managed large-scale solution portfolios deployed to healthcare systems globally.
Currently, she is Managing Director of Life Sciences at Innovation Works, one of the most active seed-stage investment organizations in the country. Previously, she served as Chief Solutions Officer at TeleTracking Technologies, where she managed a portfolio of more than 20 healthcare solutions deployed worldwide. Before that, she led large corporate development and business line divisions at Bayer Health and Medrad, bringing together her combined strengths in healthcare informatics, strategic acquisitions and operational leadership.
Jeanne Iasella
Business Advisor
Jeanne Colwell Iasella is a healthcare technology executive with deep domain expertise in healthcare informatics and extensive experience in corporate development and mergers and acquisitions. As a C-level executive and division leader, she has built and managed large-scale solution portfolios deployed to healthcare systems globally.
Currently, she is Managing Director of Life Sciences at Innovation Works, one of the most active seed-stage investment organizations in the country. Previously, she served as Chief Solutions Officer at TeleTracking Technologies, where she managed a portfolio of more than 20 healthcare solutions deployed worldwide. Before that, she led large corporate development and business line divisions at Bayer Health and Medrad, bringing together her combined strengths in healthcare informatics, strategic acquisitions and operational leadership.
Digvijay Singh
Technical Advisor
Digvijay Singh
Technical Advisor
Digvijay Singh is a Silicon Valley-based technologist, serial entrepreneur and startup advisor with nearly two decades of experience building and scaling technology companies. A five-time founder and full-stack architect, he brings deep technical expertise spanning enterprise systems, conversational AI and platform development.
Most recently, he served as Chief Technology Officer of ShearShare (acquired), where he led the company's technology strategy through to a successful exit. He is currently Consulting CTO at Aether, Chief Architect at VELMENI, and Founder of SevenOlives Inc, through which he has spent over a decade helping small and medium enterprises leverage technology to solve real-world business problems.
Digvijay Singh is a Silicon Valley-based technologist, serial entrepreneur and startup advisor with nearly two decades of experience building and scaling technology companies. A five-time founder and full-stack architect, he brings deep technical expertise spanning enterprise systems, conversational AI and platform development.
Most recently, he served as Chief Technology Officer of ShearShare (acquired), where he led the company's technology strategy through to a successful exit. He is currently Consulting CTO at Aether, Chief Architect at VELMENI, and Founder of SevenOlives Inc, through which he has spent over a decade helping small and medium enterprises leverage technology to solve real-world business problems.
Digvijay Singh
Technical Advisor
Digvijay Singh is a Silicon Valley-based technologist, serial entrepreneur and startup advisor with nearly two decades of experience building and scaling technology companies. A five-time founder and full-stack architect, he brings deep technical expertise spanning enterprise systems, conversational AI and platform development.
Most recently, he served as Chief Technology Officer of ShearShare (acquired), where he led the company's technology strategy through to a successful exit. He is currently Consulting CTO at Aether, Chief Architect at VELMENI, and Founder of SevenOlives Inc, through which he has spent over a decade helping small and medium enterprises leverage technology to solve real-world business problems.
Funding Agencies and Investors
3518 Fifth Avenue, First Floor
Pittsburgh, Pennsylvania 15213
